Back
Pliant Therapeutics Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
9
PLRX
Pliant Therapeutics
Last Price:
12.53
Seasonality Move:
40.29%
Sell
36
PLX
Protalix BioTherapeutics
Last Price:
1.21
Seasonality Move:
3.5%
Sell
9
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy, Sell or Hold?
- The current Pliant Therapeutics [PLRX] share price is $12.60. The Score for PLRX is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
- PLRX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
36
Protalix BioTherapeutics (PLX)
is a Sell
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.18. The Score for PLX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- PLX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PLRX Stock Price Chart
What is Pliant Therapeutics's stock price today?
-
The Pliant Therapeutics share price today is $12.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight buying pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.18
The current trend is relatively stagnant and PLX is experiencing buying pressure, which is a positive indicator for future bullish movement.
PLRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.71 | Sell |
Relative Strength Index (14 RSI): | 32.87 | Sell |
Chaikin Money Flow: | 16614 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.35 - 15.01) | Sell |
Bollinger Bands (100): | (14.34 - 17.56) | Sell |
PLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 41.93 | Sell |
Chaikin Money Flow: | 225065 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.17 - 1.29) | Sell |
Bollinger Bands (100): | (1.29 - 1.67) | Sell |
PLRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.2 | Sell |
20-day SMA: | 14.02 | Sell |
50-day SMA: | 15.11 | Sell |
200-day SMA: | 16.12 | Sell |
8-day EMA: | 13.08 | Sell |
20-day EMA: | 13.85 | Sell |
50-day EMA: | 14.82 | Sell |
200-day EMA: | 16.7 | Sell |
PLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.16 | Buy |
20-day SMA: | 1.21 | Sell |
50-day SMA: | 1.36 | Sell |
200-day SMA: | 1.58 | Sell |
8-day EMA: | 1.17 | Buy |
20-day EMA: | 1.22 | Sell |
50-day EMA: | 1.33 | Sell |
200-day EMA: | 1.54 | Sell |
Pliant Therapeutics Earnings Growth & PLRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.25 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Pliant Therapeutics Technical Analysis
Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Protalix BioTherapeutics Technical Analysis
Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |